This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

China opposes planned US semiconductor tariffs, warns of countermeasures

( December 24, 2025, 08:32 GMT | Official Statement) -- MLex Summary: China’s foreign ministry said Wednesday that Beijing opposes a US plan to impose additional tariffs on China’s semiconductor industry from June 2027, calling the move an unreasonable use of trade measures to suppress Chinese industries. It warned the plan would disrupt global supply chains and harm the sector’s development worldwide. Responding to a media inquiry at a regular press briefing, foreign ministry spokesperson Lin Jian urged the US to correct what he described as a misguided approach and to address differences through dialogue based on equality, respect and mutual benefit, in line with understandings reached by the two countries’ leaders. Lin said China would take resolute countermeasures to safeguard its legitimate rights and interests if Washington proceeds with the tariffs.Statement follows (Chinese)....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections